plumbagin has been researched along with Hemolysis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jilani, K; Lang, E; Lang, F; Lupescu, A; Zbidah, M | 1 |
Bothiraja, C; Kapare, HS; Pawar, AP; Shaikh, KS | 1 |
2 other study(ies) available for plumbagin and Hemolysis
Article | Year |
---|---|
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
Topics: Aniline Compounds; Annexin A5; Apoptosis; Calcium; Cell Death; Cell Membrane; Cell Size; Ceramides; Cytosol; Erythrocytes; Hemolysis; Molecular Structure; Naphthoquinones; NF-kappa B; Phosphatidylserines; Vitamin K 3; Xanthenes | 2012 |
Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.
Topics: Antineoplastic Agents, Phytogenic; Blood Proteins; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Stability; Female; Hemolysis; Humans; Kinetics; MCF-7 Cells; Micelles; Nanoparticles; Nanotechnology; Naphthoquinones; Particle Size; Phospholipids; Polysorbates; Protein Binding; Solubility; Technology, Pharmaceutical | 2013 |